Navellier & Associates Inc Pro Phase Labs, Inc. Transaction History

Navellier & Associates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$6.62 - $9.57 $91,488 - $132,257	-13,820 Reduced 19.09%	58,566 $446,000
Q4 2022 Feb 02, 2023	BUY	$8.78 - $12.47 $282,426 - $401,122	32,167 Added 79.98%	72,386 $697,000
Q3 2022 Nov 09, 2022	BUY	$8.96 - $14.7 $360,362 - $591,219	40,219 New	40,219 $454,000

1.71M

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $10.4M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.